[Asia Economy Reporter Ji Yeon-jin] Aprogen MED announced on the 16th that it will absorb and merge Aprogen (unlisted company) to maximize corporate value through improving management efficiency and corporate governance.



The Korea Exchange Market Division announced that trading of Aprogen MED will be suspended until 9:30 AM on the same day.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing